News Roundup: December 19 to December 23
Your weekly roundup of the latest news from Drug Topics®.
FDA Approves First-In-Class Twice-Yearly Treatment for HIV
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
CBD May Help Mitigate Opioid Withdrawal Symptoms
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
Examining Rates of COVID-19 Rebound With Antiviral Therapies
Research tells a different story than recent news headlines.
Copay Caps for Insulin Lower Total Spending for Medicare Beneficiaries
The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.
How General Vaccine Hesitancy Is Impacting Teen COVID-19 Vaccination Rates
The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?
Read more
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
